Aegis Capital Reiterates Buy on Globus Medical (GMED) Following 4Q EPS Miss

February 28, 2017 7:45 AM

Aegis Capital reiterated a Buy rating and $31.00 price target on Globus Medical (NYSE: GMED) following the company's 4Q earnings ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found